Literature DB >> 10079014

Theaflavin-3,3'-digallate from black tea blocks the nitric oxide synthase by down-regulating the activation of NF-kappaB in macrophages.

Y L Lin1, S H Tsai, S Y Lin-Shiau, C T Ho, J K Lin.   

Abstract

Nitric oxide (NO) plays an important role in inflammation and also in multiple stages of carcinogenesis. We investigated the effects of various tea polyphenols, including theaflavin, a mixture of theaflavin-3-gallate and theaflavin-3'-gallate, theaflavin-3,3'-digallate, thearubigin, and (-)-epigallocatechin-3-gallate on the induction of NO synthase in lipopolysaccharide-activated murine macrophages, RAW 264.7 cells. Theaflavin-3,3'-digallate was found to be stronger than (-)-epigallocatechin-3-gallate in inhibiting NO generation and inducible NO synthase protein in activated macrophages, while theaflavin, a mixture of theaflavin-3-gallate and theaflavin-3'-gallate and thearubigin were less effective. Inhibition of NO production was observed when cells were cotreated with theaflavin-3,3'-digallate and lipopolysaccharide. Western blot and reverse transcriptase-polymerase chain reaction (RT-PCR) analyses demonstrated that significantly reduced 130-kDa protein and mRNA levels of inducible NO synthase were expressed in lipopolysacchride-activated macrophages with theaflavin-3,3'-digallate, compared to those without theaflavin-3,3'-digallate. Electrophoretic mobility shift assay (EMSA) indicated that theaflavin-3,3'-digallate blocked the activation of nuclear factor kappaB (NF-kappaB), a transcription factor necessary for inducible NO synthase induction. Theaflavin-3,3'-digallate also blocked phosphorylation of IkappaB from cytosolic fraction and reduced lipopolysacchride-induced nuclear accumulation of transcription factor NF-kappaB p65 and p50 subunits. These results suggest that theaflavin-3,3'-digallate decreases the protein levels of inducible NO synthase by reducing the expression of inducible NO synthase mRNA, and the reduction could be via preventing the activation of NF-kappaB, thereby inhibiting the induction of inducible NO synthase transcription. It was also demonstrated that the gallic acid moiety of theaflavin-3,3'-digallate is essential for their potent anti-inflammation activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079014     DOI: 10.1016/s0014-2999(98)00953-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Black tea polyphenol theaflavin suppresses LPS-induced ICAM-1 and VCAM-1 expression via blockage of NF-κB and JNK activation in intestinal epithelial cells.

Authors:  Young-A Song; Young-Lan Park; Sun-Hye Yoon; Kyu-Yeol Kim; Sung-Bum Cho; Wan-Sik Lee; Ik-Joo Chung; Young-Eun Joo
Journal:  Inflamm Res       Date:  2010-12-24       Impact factor: 4.575

2.  Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties.

Authors:  Orly Weinreb; Tamar Amit; Silvia Mandel; Moussa B H Youdim
Journal:  Genes Nutr       Date:  2009-09-10       Impact factor: 5.523

3.  Evaluation of the antioxidant effects of four main theaflavin derivatives through chemiluminescence and DNA damage analyses.

Authors:  Yuan-yuan Wu; Wei Li; Yi Xu; En-hui Jin; You-ying Tu
Journal:  J Zhejiang Univ Sci B       Date:  2011-09       Impact factor: 3.066

4.  Protection from experimental colitis by theaflavin-3,3'-digallate correlates with inhibition of IKK and NF-kappaB activation.

Authors:  A Ukil; S Maity; P K Das
Journal:  Br J Pharmacol       Date:  2006-07-31       Impact factor: 8.739

5.  Structural identification of mouse fecal metabolites of theaflavin 3,3'-digallate using liquid chromatography tandem mass spectrometry.

Authors:  Huadong Chen; Tiffany A Parks; Xiaoxin Chen; Nicholas D Gillitt; Christian Jobin; Shengmin Sang
Journal:  J Chromatogr A       Date:  2011-08-25       Impact factor: 4.759

6.  Effects of the black tea polyphenol theaflavin-2 on apoptotic and inflammatory pathways in vitro and in vivo.

Authors:  Alexander Gosslau; David Li En Jao; Mou-Tuan Huang; Chi-Tan Ho; Dave Evans; Nancy E Rawson; Kuang Yu Chen
Journal:  Mol Nutr Food Res       Date:  2011-02       Impact factor: 5.914

7.  Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols.

Authors:  Wipob Suttana; Samlee Mankhetkorn; Wilart Poompimon; Ajay Palagani; Sergey Zhokhov; Sarah Gerlo; Guy Haegeman; Wim Vanden Berghe
Journal:  Mol Cancer       Date:  2010-05-03       Impact factor: 27.401

Review 8.  Neuroprotective strategies in Parkinson's disease : an update on progress.

Authors:  Silvia Mandel; Edna Grünblatt; Peter Riederer; Manfred Gerlach; Yona Levites; Moussa B H Youdim
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer.

Authors:  Lorne J Hofseth
Journal:  Cancer Lett       Date:  2008-04-25       Impact factor: 8.679

10.  Theaflavins inhibit the ATP synthase and the respiratory chain without increasing superoxide production.

Authors:  Bo Li; Steven B Vik; Youying Tu
Journal:  J Nutr Biochem       Date:  2011-09-15       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.